drugset / Trial / NCT00694746

Study of Fish Oil to Reduce ALT Levels in Adolescents

NCT00694746

Phase 1 Terminated 3 enrolled Boston University GlaxoSmithKline · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

This trial will provide preliminary data to test the hypothesis that a six-month treatment period with fish oil for overweight adolescent with mild to moderate persistent elevation of ALT levels and presence of hepatic steatosis on CT-scan is safe and will result in decreased ALT.

Timeline

Start
2008-06
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lovaza Other / unclassified 4 g

Indications